PBH — Prestige Consumer Healthcare Share News
0.000.00%
- $2.19bn
- $4.25bn
- $1.09bn
Brief: Prestige Consumer Healthcare Q3 Revenue USD 282.741 Million Vs. IBES Estimate USD 280.2 Million
Prestige Consumer Healthcare Inc expected to post earnings of $1.04 a share - Earnings Preview
Brief: Insight Pharmaceuticals Issues Voluntary Nationwide Recall Of TING Antifungal Spray
Thorne HealthTech taps former Vitamin Shoppe CEO Watts as leader
Brief: Prestige Consumer Healthcare On December 8, Entered Into Amendment No. 9 To ABL Credit Agreement
Brief: Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Prestige Consumer Healthcare Inc reports results for the quarter ended in September - Earnings Summary
Prestige Consumer Healthcare Inc expected to post earnings of $1.07 a share - Earnings Preview
Prestige Consumer Healthcare Inc reports results for the quarter ended in June - Earnings Summary
Brief: Prestige Consumer Healthcare Q1 Revenue USD 279.309 Million Vs. IBES Estimate USD 278.8 Million
Prestige Consumer Healthcare Inc expected to post earnings of $1.01 a share - Earnings Preview
Prestige Consumer Healthcare Inc reports results for the quarter ended in March - Earnings Summary
Brief: Prestige Consumer Healthcare Q4 revenue USD 285.869 million
Brief: Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023
U.S. STOCKS ON THE MOVE-Arrow Electronics, fintechs, Amazon.com,
Prestige Consumer Healthcare falls after downbeat profit forecast
Prestige Consumer Healthcare Inc reports results for the quarter ended in December - Earnings Summary
Brief: Prestige Consumer Healthcare Inc Reports Third Quarter Results
Prestige Consumer Healthcare Inc expected to post earnings of $1.01 a share - Earnings Preview